Yuko Muramatsu

SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats

Masanori Yokono, Toshiyuki Takasu, Yuka Hayashizaki et al. · European Journal of Pharmacology · 2014 · 190 citations · Full text

Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo

Akinori Iwashita, Yuko Muramatsu, Takao Yamazaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 140 citations

Neuroprotective efficacy of FR901459, a novel derivative of cyclosporin A, in in vitro mitochondrial damage and in vivo transient cerebral ischemia models

Yuko Muramatsu, Yasuhisa Furuichi, Nobuteru Tojo et al. · Brain Research · 2007 · 30 citations

Mitochondrial Function, Vitro Mitochondrial Damage, Medicine +13

WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production, Purification and Structure lucidation.

TAKANAO OTSUKA, Yuko Muramatsu, Tomoji Higaki et al. · The Journal of Antibiotics · 1999 · 16 citations · Full text

Novel neuroprotective compound SCH-20148 rescues thymocytes and SH-SY5Y cells from thapsigargin-induced mitochondrial membrane potential reduction and cell death

Yuko Muramatsu, Takuya Maemoto, Akinori Iwashita et al. · European Journal of Pharmacology · 2007 · 15 citations

Sh-sy5y Cells, Mitochondrial Function, Medicine +9